DRKS00000360
Active, not recruiting
Phase 2
Prospective, randomised, doubleblind, placebo controlled trial on changes in acetylcholine receptor antibody titers in autoimmune myasthenia gravis after influenza vaccination EudraCT-Nr. 2006-004374-27 - ProPATIent
Philipps-Universität MarburgKoordinierungszentrum für Klinische Studien (KKS)0 sites63 target enrollmentMarch 11, 2010
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- G70.0
- Sponsor
- Philipps-Universität MarburgKoordinierungszentrum für Klinische Studien (KKS)
- Enrollment
- 63
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •written informed consent
- •age at least 18 years
- •age of 80 years maximum
- •diagnosis of myasthenia gravis according the guideline of the German Neurological Society
- •positve anti\-AChR abs
- •clinically stable for at least 4 months
Exclusion Criteria
- •any vaccination within 9 months prior to study entry
- •history of severe heart disease
- •cardiac arrythmia
- •History of cancer
- •acute infection at screening or Visit 1
- •allergy against chicken protein
- •History of severe vaccination reaction
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Prospective, randomized, doubleblind, placebo-controlled trial on changes in acetylcholine receptor antibody titres in autoimmune myasthenia gravis after influenza vaccination (ProPATIent) - ProPATIentGeneralized Myasthenia gravis with positive antibodies against Acetylcholine-receptors (ICD10GM2006 G70.0)EUCTR2006-004374-27-DEPhilipps-University
Recruiting
Not Applicable
Comparative study of the effect of the intervention of real Transcranial Led Therapy and placebo, on anxiety and depression with patients with TBI.Craniocerebral Trauma, anxiety, depression, Pathological conditions, signs and symptoms, Low-Level Light TherapyC10.900.300F01.470.132F01.145.126.350E02.594.540RBR-8jcwjpCentro Universitário UniFacid
Active, not recruiting
Phase 1
Double blind, randomised, prospective placebo controlled parallel group phase III study to investigate the Effect of EGCG supplementation on disease progression of patients with Multiple System Atrophy (MSA)EUCTR2012-000928-18-DEHospital of the Ludwig-Maximilians-University of Munich86
Completed
Not Applicable
Antioxidant therapy in implementing lithotripsy in patients with renal lithiasisKidney stone disease treated by extracorporeal shockwave lithotripsyUrological and Genital DiseasesCalculus of kidney and ureterISRCTN98702137Reina Sofia Universitary Hospital (Spain)126
Active, not recruiting
Phase 1
Comparison of treatment with sexual hormones and psychotherapy over 10 weeks vs. psychotherapy only in adult females with anorexia nervosaEUCTR2015-004184-36-DEniversitätsklinikum Erlangen30